Find out the deciding factor(total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index, skeletal muscle mass, body fat) of neuromuscular blocker dose for deep neuromuscular blockade in bariatric surgery.
Before the surgery, total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index were measured by height and weight and skeletal muscle mass and body fat were measured by Bioelectrical impedance analysis (InbodyH20B). Find the highest correlation between the 8 factors (total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index, skeletal muscle mass, body fat) and the amount of rocuronium administered to deep neuromuscular blockade in bariatric surgery.
Study Type
OBSERVATIONAL
Enrollment
90
obese patients who underwent bariatric surgery
the highest correlation coefficient
the relationship of rocuronium for deep neuromuscular blockade in bariatric surgery and 8 factors (corrected body weight, ideal body weight, lean body weight, fat-free mass, body mass index, skeletal muscle mass, body fat)
Time frame: preoperative 1 days to postoperative 1 days
onset time of rocuronium
time from injection of rocuronium 0.6 mg/kg(TBW) to TOF ratio is less than 0.05
Time frame: preoperative 1 days to postoperative 1 days
time to deep neuromuscular blockade
time from injection of rocuronium 0.6 mg/kg(TBW) to PTC 1
Time frame: preoperative 1 days to postoperative 1 days
Recovery time
time from sugammadex injection to TOF ratio \> 0.9
Time frame: preoperative 1 days to postoperative 1 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.